Results 11 to 20 of about 5,282,141 (310)

Rosalind and Morris Goodman Cancer Research Centre Annual Symposium | May 6-7, 2021

open access: yesMcGill Journal of Medicine, 2021
n ...
The Rosalind and Morris Goodman Cancer Research Centre (GCRC)
doaj  

Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer

open access: yesCancer Innovation, 2022
Phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) signaling pathway (PAM pathway) plays an important role in the development of breast cancer and are closely associated with the resistance to endocrine ...
The Society of Clinical Research of Oncology Medications of China Anticancer Association   +2 more
doaj   +1 more source

Disulfide-Modified Mesoporous Silica Nanoparticles for Biomedical Applications

open access: yesCrystals, 2023
Mesoporous silica nanoparticles (MSNs) are highly porous carriers used in drug and gene delivery research for biomedical applications due to their high surface area, narrow particle size distribution, and low toxicity.
Melissa Venedicto   +5 more
doaj   +1 more source

A retrospective cohort study of the influence of lifestyle factors on survival of patients undergoing surgery for colorectal cancer. [PDF]

open access: yes, 2017
Aim: Several modifiable and non-modifiable health related behaviours are associated with the incidence of Colorectal Cancer (CRC), but there is little research on their association with survival.
Anderson   +21 more
core   +1 more source

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies [PDF]

open access: yes, 2017
We would like to thank all patients whose samples were used in this study. We are also thankful to the Northern Ireland Biobank and Grampian Biorepository for providing us with tissue blocks and patient data; and Dr HG Coleman (Queen’s University Belfast)
A Gonçalves   +39 more
core   +2 more sources

The state of cancer research in fragile and conflict-affected settings in the Middle East and North Africa Region: A bibliometric analysis

open access: yesFrontiers in Oncology, 2023
BackgroundCancer represents a disproportionate burden in LMICs, especially conflict-affected countries in the MENA region. Research output on cancer fails to match the growing burden in the region.
Zahi Abdul Sater   +8 more
doaj   +1 more source

TOX3 mutations in breast cancer [PDF]

open access: yes, 2013
TOX3 maps to 16q12, a region commonly lost in breast cancers and recently implicated in the risk of developing breast cancer. However, not much is known of the role of TOX3 itself in breast cancer biology.
Caldas, Carlos   +6 more
core   +3 more sources

Standard operating procedures for biobank in oncology

open access: yesFrontiers in Molecular Biosciences, 2022
Biobanks are biorepositories that collect, process, store, catalog, and distribute human biological samples, and record the associated data. The role and action field of these strategic infrastructures for implementing precision medicine in translational
Giuseppina Bonizzi   +18 more
doaj   +1 more source

Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes [PDF]

open access: yes, 2014
© 2014 Glover et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and ...
Academy of Medical Sciences   +48 more
core   +5 more sources

Lab-on-Chip Platform for Culturing and Dynamic Evaluation of Cells Development

open access: yesMicromachines, 2020
This paper presents a full-featured microfluidic platform ensuring long-term culturing and behavioral analysis of the radically different biological micro-objects.
Agnieszka Podwin   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy